Precision Medicine Market

Precision Medicine Market - Global Market Share, Trends, Analysis and Forecast, 2024-2033
Frequently asked questions about this report

The precision medicine market is estimated to be US$ 1.83 Billion in 2023. The market is projected to reach US$ 6.28 Billion by 2033.

The precision medicine market is expected to grow at a CAGR of 13.1% between 2024 to 2033.

The precision medicine market was valued at US$1.62 Billion in 2022.

The convergence of technological advancements, growing disease burden, and supportive policies has been instrumental in driving the global precision medicine market, , with the promise of more precise and personalized healthcare solutions driving its continued growth.

Oncology is the largest application segment in the market due to its potential in revolutionizing cancer treatment by analyzing genetic and molecular profiles to tailor personalized therapies.

Allscripts Healthcare Solutions Inc, Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., PierianDx Inc., Qiagen N.V., Roche Holdings Inc., Roper Technologies Inc., Sophia Genetics SA, Synapse Inc. among others, are the key players in this market.